IBUB

Institut de Biomedicina de la Universitat de Barcelona

Drug and target discovery for biomedical science

The Institute of Biomedicine of the University of Barcelona (IBUB) is a transversal research unit formed by some 40 groups from the Faculties of Biology, Chemistry and Pharmacy and Food Sciences. The IBUB was created in 2006 with the aim of identifying, beyond the traditional academic structures (departments and faculties), a set of laboratories with complementary scientific activity, capable of generating synergies.

News

Technology Transfer Opportunities

One of the key strengths of IBUB is its ability to successfully transfer knowledge to society

Projects

314

Research groups

40

Publications

725

Research

The Institute of Biomedicine brings together highly qualified biomedical research personnel working in groups renowned for their excellence, and its founding collective’s indicators in scientific production and the raising of resources testify to the IBUB’s benchmark status in biomedical research in both Catalonia and the rest of Europe.

Research Programs

IBUB is comprised of research groups actively coordinated in the form of differents programs and nodes

Research Groups

IBUB consists of different specialized research groups

Seminars

Preclinical testing of personalized CRISPR therapies for Duchenne Muscular Dystrophy

Óscar Gutiérrez, Stem Cell Unit, Univ. Medical Center Göttingen

Date

October 31, 2024

Time

16:00h

Place

A14, Ed. Durfort, Fac. Biology

Cellular Senescence: Search and Destroy

Manuel Collado, CNB-CSIC, Universidade de Santiago de Compostela

Date

October 31, 2024

Time

15:30

Place

A14, Ed. Durfort, Fac. Biology

Understanding how Peroxisomes regulate Mitochondria in health and disease

Peter Kim, Hospital for Sick Children Research Inst., U. of Toronto.

Date

September 30, 2024

Time

13:00h

Place

A-15, Fac. Biology

Article of the month

Agueda Castro-Quintas, Helena Palma-Gudiel, Elisenda Eixarch, Nerea San Martín González, Simone Röh, Susann Sauer, Monika Rex-Haffner, Jose Luis Monteserin-Garcia, Lorena de la Fuente-Tomás, Fatima Crispi, Maria Paz Garcia Portilla, Elisabeth B. Binder, Lourdes Fañanas

European Neuropsychopharmacology

Placental epigenetic signatures of maternal distress in glucocorticoid-related genes and newborn outcomes: A study of Spanish primiparous women

Maternal stress during pregnancy can impact offspring health, increasing the risk of neuropsychiatric disorders. The human placenta plays a crucial role in understanding this effect, influencing fetal programming as it connects maternal and fetal circulation. Our hypothesis centers on maternal stress influencing children’s outcomes through placental DNA methylation, targeting three cortisol-regulating genes: NR3C1, FKBP5, and HSD11B2.
In this pilot study, chorionic villi and maternal decidua placental layers from 45 mother-infant dyads (divided into two groups based on high/low maternal stress exposure) were analyzed for DNA methylation at the genes of interest via targeted bisulfite sequencing. Pregnant women provided four saliva samples throughout a day for cortisol determinations and were assessed for the presence of depressive symptoms at each of the three trimesters of pregnancy. Newborns underwent neurodevelopmental assessments and salivary cortisol evaluations at 7 weeks.
Increased maternal diurnal cortisol levels in the first trimester of pregnancy was significantly associated with elevated DNA methylation at exon 1D of the NR3C1 gene and lower DNA methylation at intron 7 of the FKBP5 gene, both in chorionic villi samples. Elevated DNA methylation at introns 1 and 7 of FKBP5 in the maternal decidua were strongly linked to an anticipated delivery. DNA methylation at the HSD11B2 promoter region was uniformly low across all placental samples. No associations with newborn neurodevelopment were found.
These results emphasize the importance of exploring layer-specific methylation differences at distinct pregnancy stages, highlighting the complex interplay between maternal stress, placental epigenetic modifications, and fetal development throughout the prenatal period.

Announcements

MCP Lab offers a predoctoral contract associated with a project of the AGAUR Program “Indústria del Coneixement”

Data límit

20/1/2024 - Send CV and motivation letter

ENDED- Call for 6 research initiation grants 2023-2024

Data límit

3 d'octubre 2023. Més informació: https://www.ub.edu/ibub/call-for-6-research-initiation-grants-2023-2024/ Convocatòria: https://seu.ub.edu/ajutsPublic/showPublicacion/441657

Contact

Institut de Biomedicina de la Universitat de Barcelona, IBUB

Departament de Bioquímica i Biomedicina Molecular

Facultat de Biologia / Secretaria IBUB & Bioinformàtica
Avda. Diagonal, 643
Edifici Prevosti, planta -1
08028 Barcelona

+34 606 14 87 72
ibub@ub.edu

Our partners